Trials / Recruiting
RecruitingNCT06365424
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
An Open Label Long-Term Study to Evaluate the Safety and Effectiveness of Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 117 (estimated)
- Sponsor
- Xijing Hospital of Digestive Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
An Open Label Long-Term Study to Evaluate the Safety and Effectiveness of Fenofibrate in Subjects with Primary Biliary Cholangitis (PBC)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fenofibrate | Fenofibrate (200 mg/day) |
| DRUG | UDCA | Ursodeoxycholic acid (13-15 mg/kg/day) |
Timeline
- Start date
- 2017-04-08
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
- First posted
- 2024-04-15
- Last updated
- 2025-07-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06365424. Inclusion in this directory is not an endorsement.